בשל "הגנת זכויות יוצרים" מובא להלן קישור לתקציר המאמר. לקריאתו בטקסט מלא, אנא פנה/י לספרייה הרפואית הזמינה לך. 

Due to the high prevalence of asthma and general airway reactivity, anesthesiologists frequently encounter children with asthma or asthma-like symptoms.

This review focuses on the epidemiology, the underlying pathophysiology and perioperative management of children with airway reactivity, including controlled and uncontrolled asthma.

It spans from preoperative optimization to optimized intraoperative management, airway management and ventilation strategies. There are three leading causes for bronchospasm 1) Mechanical (e.g. airway manipulation), 2) Non-immunological anaphylaxis (anaphylactoid reaction): 3) Immunological-anaphylaxis.

Children with increased airway reactivity may benefit from a premedication with beta-2 agonists, non-invasive airway management and deep removal of airway devices.

While desflurane should be avoided in pediatric anesthesia due to an increased risk of bronchospasm, other volatile agents are potent bronchodilators.

 Propofol is superior in blunting airway reflexes and, therefore well suited for anesthesia induction in children with increased airway reactivity.